Abstract
Strains of Streptomyces verticillus native to the soil of the coal mining country of Fukuoka Prefecture, Japan can elaborate heterogeneous antibiotic substances (i.e., phleomycin and bleomycin) with a capacity to block DNA synthesis, inhibit proliferation of replicative RNA’s, and prevent higher cells from entering meiotic or mitotic division. These actions can occur separately, possibly because they depend on different specific compounds present in phleomycin and bleomycin. These actions were discovered at different times and in different laboratories during independent investigations. Reported separately, they created a confusing and conflicting literature on the action of phleomycin-bleomycin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, R. L. P., Abrams, R., Lieberman, I.: Rise in deoxyribonucleic acid polymerase activity in the absence of deoxyribonucleic acid synthesis in cultured kidney cells. Nature (Lond.) 206, 512–513 (1965).
Adams, R. L. P., Abrams, R., Lieberman, I.: Deoxycytidylate synthesis and entry into the period of deoxyribonucleic acid replication in rabbit kidney cells. J. biol. Chem. 241, 903–905 (1966).
Bittar, E. E.: Effect of aldosterone on Na efflux in single Maia fibers. Biochem. biophys. Res. Comm. 23, 868–873 (1966).
Bittar, E. E.: Insulin and the sodium pump of the Maia muscle fiber. Nature (Lond.) 214, 726–727 (1967).
Bittar, E. E., Dick, D. A. T., Ery, D. J.: Effects of aldosterone on Na efflux in single oocytes of Bufo bufo. J. Physiol. 184, 23P (1966).
Bradner, W. T., Pindell, M. H.: Antitumor properties of phleomycin. Nature (Lond.) 196, 683–684 (1962).
Bradner, W. T., Pindell, M. H.: Strain of stimulated regression of Sarcoma 180. Cancer Res. 25, 859–864 (1965).
Bradner, W. T., Pindell, M. H.: Myeloid leukemia C149P as a screen for cancer chemotherapeutic agents. Cancer Res. 26, 375–390 (1966).
Cavalieri, L.F.: Nucleic acids and information transfer. J. cell. comp. Physiol. 62, 111–122 (1963).
Djordjevic, B., Kim, J. H.: Lethal effect of phleomycin in different stages of the division cycle of HeLa cells. Cancer Res. 27, 2255–2260 (1967).
Dold, U., Schmidt, C. G.: Cytostatically active antibiotics. Internist 12, 136–142 (1971).
Falaschi,A., Kornberg, A.: Phleomycin, an inhibitor of DNA polymerase. Fed. Proc. 23, 940–945 (1964).
Fanestil, D.: The mechanism of action of aldosterone on sodium transport; effect of inhibitors of DNA synthesis. Life Sci. 7, 191–195 (1968).
Fukatsu, H., Yoshida, K.: Three cases of penile cancer—clinical use of a new antineoplastic antibiotic, bleomycin. Iryo. 23, 694–697 (1969) (in Japanese).
Giese, A. C.: Macromolecular synthesis during regeneration in Blepharisma determined by specific inhibitors and incorporation of carbon-14 labeled tracers. Exp. cell. Res. 61, 91–102 (1970).
Gorman, T., Pietsch, P.: Strategy for crystallographic analysis of phleomycin-DNA complexes: Fournier transforms. Physiol. Chem. Phys. 1, 312–316 (1969).
Grigg, G. W.: Induction of DNA breakdown and death in Escherichia coli by phleomycin. Its association with dark-repair processes. Molec. gen. Genetics 104, 1–11 (1969).
Grigg, G. W.: Amplification of phleomycin induced death and DNA breakdown by caffeine in Escherichia coli. Molec. gen. Genetics 107, 162–172 (1970).
Hanson, C. V.: A study of rapid hydrogen exchange in nucleic acids. J. molec. Biol. 58, 847–863 (1971).
Hasegawa, Y., Irikura,T., Mizuno, D.: Screening test for the prevention of metastasis produced by Ehrlich carcinoma cells. Chem. pharm. Bull. 18, 810–814 (1970).
Hecht, T., Summers, D. F.: Effect of phleomycin on polio virus RNA replication. Virology 40, 441–447 (1970).
Heinemann, B., Howard, A. J.: Antiphage properties of compounds possessing both antitumor and inducing activities. Antimicrob. Ag. Chemother. 1964, 126–130 (1965a).
Heinemann, B., Howard, A. J.: Effect of compounds with both antitumor and bacteriophage- inducing activities on Escherichia coli nucleic acid synthesis. Antimicrob. Ag. Chemother. 1964, 488–492 (1965b).
Higuchi, M., Goto, K., Fujimoto, M., Namiki, O., Kikuchi, G.: Effect of inhibitors of nucleic acid and protein synthesis on the induced synthesis of bacteriochlorophyll and (5-amin- levulinic acid synthesis by Rhodopseudomonas spheroides. Biochim. biophys. Acta (Amst.) 95, 94–110 (1965).
Honda, Y., Ohmori, K., Yoshida, K., Arai, K.: Experimental treatment of papilloma with bleomycin. Oto-Rhino-Laryngol. (Tokyo) 12, 247–252 (1969) (in Japanese).
Hori, M., Ito, E., Umezawa, H.: Inhibitory effects of antitumor substances on growth and glycolysis of Yoshida rat sarcoma cells. J. Antibiot. A16, 1–6 (1963).
Horwitz, S. B., Chang, S. C., Grollman, A. P., Bořkovec, A. B.: Chemosterilant action of anthramycin: a proposed mechanism. Science 174, 159–161 (1971).
Hotta, Y., Stern, H.: Action of phleomycin on meiotic cells. Cancer Res. 29, 1699–1706 (1969).
Ichikawa, T.: On an antineoplastic agent, bleomycin. Naika 22, 630–633 (1968) (in Japanese).
Ichikawa, T., Nakano, I., Hirokawa, I.: Bleomycin treatment of the tumors of penis and scrotum. J. Urol. 102, 699–707 (1969).
Ichikawa, T.: A new antineoplastic agent, bleomycin—its effect on squamous cell carcinoma. J. Jap. med. Assoc. 61, 487–497, (1969a) (in Japanese).
Ichikawa, T.: New antineoplastic agent, bleomycin, with special reference to its notable effect on squamous cell carcinoma. Jap. J. clin. Med. 27, 1618–1626 (1969b).
Ichikawa, T.: Discovery of the effect of bleomycin on squamous cell carcinoma and development of its research. J. Jap. med. Assoc. 62, 153–158 (1969c) (in Japanese).
Ichikawa, T., Matsijda, A., Miyamoto, K., Tsubosaki, M., Kaihara, T., Sakamoto, K., Umezawa, H.: Biological studies on bleomycin A. J. Antibiot. 20, 149–155 (1967).
Ichikawa, T., Umezawa, H.: Clinical study on a new antitumor antibiotic, bleomycin. Proc. 5th Int. Congr. Chemotherapy 507 (1967).
Iijima, T., Ikeda, Y.: Mutability of the phleomycin-resistant mutants of Bacillus subtilis. I. Isolation of genetically unstable mutants. J. gen. appl. Microbiol. 16, 419–427 (1970).
Ikeda, K., Egami, F.: Effects of antibiotics and antimetabolites on the induced formation of pyocin R. Z. Allg. Mikrobiol. 6, 219–225 (1966).
Ikeda, Y., Iijema, T., Tajima, K.: Elimination of F-episome from a male strain of Escherichia coli by treatment with sarkomycin and a related antibiotic. J. gen. appl. Microbiol. 13, 247–254 (1967).
Ikekawa, T., Iwami, F., Hiranaka, H., Umezawa, H.: Separation of phleomycin components and their properties. J. Antibiot. A17, 194–199, 1964.
Inuyama, Y., Machukawa, J.: Effect of 5-fluorouracil and bleomycin on malignant head and neck tumors. Otolaryngol. 41, 901–909 (1969) (in Japanese).
Ishizuka, M., Takayama, H., Takeuchi, T., Umezawa, H.: Studies on antitumor activity, antimicrobial activity and toxicity of phleomycin. J. Antibiot. A19, 260–271 (1966).
Ishizuka, M., Takayama, H., Takeuchi, T., Umezawa, H.: Activity and toxicity of bleomycin. J. Antibiot. A20, 15–24 (1967).
Iwata, A., Consigli, R. H.: Effect of phleomycin on polyoma virus synthesis in mouse embryo cells. J. Virol. 7, 29–40 (1971).
Jacobs, N. F., Neu, R.L., Gardner, L. T.: Phleomycin-induced mitotic inhibition and chromosomal abnormalities in cultured human leukocytes. Mutat. Res. 7, 251–253 (1969).
Jaffe, J.: Sensitivity of Trypanosoma equiperdum to the action of tumor-inhibitory antibiotics in vivo. Nature (Lond.) 218, 704–705 (1967).
Jagiello, G. M.: Action of phleomycin on the meiosis of the mouse ovum. Mutat. Res. 6, 289–295 (1968).
Kajiwara, K., Kim, U. H., Mueller, G. C.: Phleomycin, an inhibitor of replication of HeLa cells. Cancer Res. 26, 233–236 (1966).
Kanno, T., Kudo, T., Nakazawa, T., Takeuchi, T., Umezawa, H.: Bleomycin as an anti-brain tumor antibiotic. II. The distribution of 3H bleomycin A2(—Cu) in the experimental brain tumor of the mouse. Clin. Neurol. (Tokyo) 10, 501–506 (1970) (in Japanese).
Kato, S., Hara, I., Abe, H., Ikeda, T., Yamagami, K., Uchiya, M., Shimomura, G.: Treatment for cancer of the female genital organs with an antineoplastic agent, bleomycin. Sanfujinka no Jissai 19, 204–215 (1970) (in Japanese).
Kihlman, B. A., Odmark, G., Hartley, B.: Studies on the effects of phleomycin on chromosome structure and nucleic acid synthesis in Vicia faba. Mutat. Res. 4, 783–790 (1967).
Kimura, K., Sakai, Y., Konda, T., Kashiwada, N., Kitahara, T., Inagaki, J., Sakano, K., Fujita, H., Iizuka, N., Mikuni, M.: Chemotherapy of malignant lymphoma, with special reference to the effect of bleomycin. Jap. J. clin. Med. 27, 1593–1601 (1968) (in Japanese).
Koch, G.: Differential effect of phleomycin on the infectivity of poliovirus and poliovirus- induced ribonucleic acids. J. Virol. 8, 28–34 (1971).
Koyama, G., Nakamura, H., Muraoka, Y., Takita,T., Maeda, K., Umezawa, H.: The chemistry of bleomycin. II. The molecular and crystal structure of a sulfur-containing chromophoric amino acid. Tetrahedron Let. 44, 4635–4638 (1968).
Kunimoto, T., Hori, M., Umezawa, H.: Modes of action of phleomycin, bleomycin, and formycin on HeLaS3 cells in synchronized culture. J. Antibiot. A20, 277–281 (1967).
Lein, J., Heinemann, B., Gourevitch, A.: Induction of lysogenic bacteria as a method of detecting potential antitumor agents. Nature (Lond.) 196, 783–784 (1962).
Maeda, K., Kosaka, H., Yagishita, K., Umezawa, H.: A new antibiotic, phleomycin. J. Antibiot. A9, 82–85 (1956).
Mattingly, E.: Induction of chromosome and chromatid type aberrations by phleomycin. Mutat. Res. 4, 51–57 (1967).
Mitsuhashi, S., Takahashi, H.: Drug-resistance of enteric bacteria 19. Stability of the transmissible drug-resistance (R) factor in the host cell. Gunma J. med. Sci. 13, 129 - 134 (1964).
Mitsuya, H., Kondo, A., Senda, H., Yamanchi, T.: (Clinical study with bleomycin on penile cancer: experience in 5 cases.) Nishinihon J. Urol. 31, 270–272 (1969) (in Japanese).
Muraoka, Y., Takita, T., Maeda, K., Umezawa, H.: Chemistry of bleomycin. IV. Structure of amine component II of bleomycin A2. J. Antibiot. 23, 252–253 (1970).
Nagai, K., Suzijki, H., Tanaka, N., Umezawa, H.: Decrease of melting temperature and single strand scission of DNA by bleomycin in the presence of 2-mercaptoethanal. J. Antibiot. A22, 569–573 (1969a).
Nagai, K., Suzuki, H., Tanaka, N., Umezawa, H.: Decrease of melting temperature and single strand scission of DNA by bleomycin in the presence of hydrogen peroxide. J. Antibiot. A22, 624–628 (1969b).
Nagai, K., Yamaki, H., Suzuki, H., Tanaka, N., Umezawa, H.: The combined effects of bleomycin and sulfhydryl compounds on the thermal denaturation of DNA. Biochim. biophys. Acta (Amst.) 179, 165–171 (1968).
Nagatsu, M., Okagaki, T., Richart, R. M., Lambert, A.: Effects of bleomycin on nuclear DNA in transplantable VX-2 carcinoma of rabbit. Cancer Res. 31, 992–996 (1971).
Nakamura, S., Murakami, Y., Hashiguchi, T., Kuga, G., Yanagi, Y., Fujimoto, N., Masuda, Y.: (Clinical and pathological observations on malignant tumors of the head and neck region treated with bleomycin.) Otolaryngol. 41, 465–477 (1969) (in Japanese).
Nanjo, S., Suga, A.: (Case report of lingual papilloma—electron microscopic observation of bleomycin.) J. Otolaryngol. Jap. 73, 237–244 (1970) (in Japanese).
Neubert, D.: Vergleichende Untersuchungen über die Nucleinsäuresynthese in Zellkernen und Mitochondrien und ihre Beeinflußbarkeit durch Pharmaka. Arch. exp. Pathol. Pharmakol. 253, 152–176 (1966).
Oka, S., Sato, K., Nakai, Y., Kurita, K., Hashimoto, K., Oshibe, M.: Treatment of lung cancer with bleomycin. Sci. Rep. Res. Inst. Tahoku Univ. 16, 30–36 (1969).
Palmer, W. M., Fridhandler, L.: Effects of growth-inhibiting antibiotics on macromolecule biosynthesis in preimplantation rabbit conceptus. Fertil. Steril. 19, 273–285 (1968).
Pasternak, J., Samoiloff, M. R.: The effect of growth inhibitors on post-embryonic development in the free-living nematode, Pangrellus silusiae. Comp. Biochem. Physiol. 33, 27–38 (1970).
Pietsch, P.: Differences in DNA synthesis as reflected in variations in the acute inhibition of replication by the antibiotic, phleomycin. Anat. Ree. 157, 301 (1967a).
Pietsch, P.: A structural hypothesis concerning the general mode of action of phleomycin, a specific inhibitor of DNA synthesis. Anat. Ree. 157, 402 (1967b).
Pietsch, P.: Phleomycin: biological and chemical variations in different batches. Microbios. 1, 387–392 (1969a).
Pietsch, P.: Structural events in DNA in transcription and replication: the influence of histones on in vitro reactions of actinomycin-D and phleomycin-909. Cytobios. 4, 375–391 (1969b).
Pietsch, P., Clapper, G.: Receptivity of DNA to phleomycin. Cytobios. 1, 145–152 (1969).
Pietsch, P., Corbett, C.: Competitive effects of phleomycin and mercuric chloride in vivo. Nature (Lond.) 219, 933–934 (1968).
Pietsch, P., Corbett, C., Briden, D.W., Jewett, G.: Diffusability of phleomycin studied by means of neutron activation analysis. Physiol, ehem. Phys. 1, 232–236 (1969).
Pietsch, P., Eng, R.: Phleomycin: enhancement of properties by treatment with acid. Microbios. 1, 213–231 (1969).
Pietsch, P., Garrett, H.: Primary site of reaction in the in vitro complex of phleomycin in DNA. Nature (Lond.) 219, 488–489 (1968).
Pietsch, P., Garrett, H.: Phleomycin: evidence of in vivo binding to DNA. Cytobios. 1, 7–15 (1969a).
Pietsch, P., Garrett, H.: Phleomycin induced changes in the ultrastructure of DNA. Biophys. J. A9, 126 (1969b).
Pietsch, P., McCollister, S. B.: Replication and the activation of muscle differentiation. Nature (Lond.) 208, 11702–1173 (1965).
Pitts, J., Sinsheimer, R. L.: Effect of phleomycin on replication of bacteriophage 0X174. J. molec. Biol. 15, 676–680 (1966).
Price, K. E., Bradner, W. T., Buck, R. E., Lein, J.: Synergistic antimicrobial and antitumor effects of phleomycin and fluorinated pyrimidines. Antimicrob. Ag. Chemother. 1904, 481–487 (1965).
Price, K. E., Buck, R. E., Lein, J.: System for detecting inducers of lysogenic Escherichia coli W1709 (A) and its applicability as a screen for antineoplastic antibiotics. Appl. Microbiol. 12, 428–435 (1964).
Price, K. E., Buck, R. E., Lein, J.: Incidence of antineoplastic activity among antibiotics found to be inducers of lysogenic bacteria. Antimicrob. Ag. Chemother. 1964, 505–517 (1965).
Printz, M. P., von Hippel, P. H.: Hydrogen exchange studies of DNA structure. Proc. nat. Acad. Sci. (Wash.) 58, 363–370 (1965).
Rakieten, N., Nadkarni, M.V., Rakieten, M. L., Gordon, B.S.: Toxicologic and pharmacologic evaluation of phleomycin, including special studies on its nephrotoxicity. Toxicol, appl. Pharmacol. 14, 590–602 (1969).
Redon, H.: Study of the clinical efficiency of bleomycin in human cancer. Brit. med. J. 2, 643–645 (1970).
Richmond, J. E., Glaeser, R. M., Todd, P.: Protein synthesis and aggregation of embryonic cells. Exp. Cell Res. 52, 43–58 (1968).
Smale, B. C., Montgillion, M. D., Pridham, T. G.: Phleomycin, an antibiotic markedly effective for control of bean rust. Plant Dis. Rep. 45, 244 (1961).
Sober, H. A.: Handbook of Biochemistry. Selected data for molecular biology. Cleveland: The Chemical Rubber Co. 1968.
Suzuki, H.: On the mechanism of action of bleomycin: scission of DNA strands in vitro and in vivo. J. Antibiot. 22, 446–448 (1969b).
Suzuki, H., Nagai, K., Akutsu, E., Yamaki, H., Tanaka, N., Umezawa, H.: Mechanism of action of bleomycin. Strand scission of DNA caused by bleomycin and its binding to DNA in vitro. J. Antibiot. 28, 473–480 (1970).
Suzuki, H., Nagai, K., Yamaki, H., Tanaka, N., Umezawa, H.: Mechanism of action of bleomycin. Studies with the growing culture of bacterial and tumor cells. J. Antibiot. A21, 379–386 (1968).
Suzuki, H., Nagai, K., Yamaki, H., Tanaka, N., Umezawa, H.: On the mechanism of action of bleomycin: scission of DNA strands in vitro and in vivo. J. Antibiot. 22, 446–468 (1969a).
Suzuki, M., Murai, A., Watanabe, A., Nunokawa, O.: Treatment of cancer of the female genital organs with a new anti-cancer agent, bleomycin. Acta med. biol. 17, 259–275 (1970).
Suzuki, M., Nomura, H., Ito, M., Kasamatu, T., Nakanishi, K., Yamaoka, S., Misoo, Y., Takamisawa, Y., Suzuki, T., Takeda, T., Iizima, H., Kuto, J., Kinoshita, S., Moriya, K., Murai, J., Hasegawa, K., Watanabe, K., Ootake, S., Fushekawa, O.: Therapy of cancer of the female genitalia with a new antineoplastic drug, bleomycin—basic study of bleomycin. Sanfujin Jissai 18, 375–379 (1969a) (in Japanese).
Suzuki, M., Nomura, H., Ito, M., Kasamatu, T., Nakanishi K., Yamaoka, S., Misoo, Y., Takamisawa, Y., Suzuki, T., Takeda, T., Iizima, H., Kuto, J., Kinoshita, S., Moriya, K., Murai, J., Hasegawa, K., Watanabe, K., Ootake, S., Fushekawa, O.: Therapy of gynecologic tumors with a new antineoplastic agent, bleomycin—clinical study. Sanfujin Jissai 18, 574–581 (1969b) (in Japanese).
Suzuki, Y., Miyake, K.: Clinical use of bleomycin in malignant tumor of the head and neck. J. Jap. med. Assoc. 62, 112–117 (1969) (in Japanese).
Takeda, K., Sawawa, Y., Arakawa, T.: Therapeutic effects of bleomycin for skin tumors. Gann 61, 207–218 (1970) (in Japanese).
Takeuchi, M., Yamamoto, T.: Effects of bleomycin on mouse transplantable tumors. J. Antibiot. A21, 631–637 (1968).
Takeuchi, T.: Inhibition of resistant dysentery bacilli by phleomycin. J. Antibiot. A16, 172 (1963).
Takita, T.: Studies on purification and properties of phleomycin. J. Antibiot. A12, 285–289 (1959).
Takita, T., Maeda, K., Umezawa, H.: Chemistry of bleomycin. III. The sugar moieties of bleomycin A2. J. Antibiot. A22, 237–239 (1969).
Takita, T., Muraoka, Y., Maeda, K., Umezawa, H.: Chemical studies on bleomycin. I. The acid hydrolysis products of bleomycin A2. J. Antibiot. A21, 79–80 (1968).
Tanaka, N.: Effect of phleomycin on DNA polymerase of tumor origin. J. Antibiot. A18, 111 (1965).
Tanaka, N.: Inhibition of transcription by pluramycin and bleomycin. J. Antibiot. A28, 523–530 (1970).
Tanaka, N., Yamaguchi, H., Umezawa, H.: Mechanism of action of phleomycin. J. Antibiot. A16, 86–91 (1963a).
Tanaka, N., Yamaguchi, H., Umezawa, H.: Mechanism of action of angustmycins, mikamycins, and phleomycin. Jap. J. med. Sci. Biol. 16, 240–246 (1963b).
Tanaka, N., Yamaguchi, H., Umezawa, H.: Mechanism of action of phleomycin, a tumorinhibitory antibiotic. Biochem. biophys. Res. Commun. 10, 171–174 (1963c).
Tepper, H.B., Hollis, C.A., Galson, E.C., Sondheimer, E.: Germination of Fraxinus ornus embryos with and without phleomycin. Plant Physiol. 42, 1483–1486 (1967).
Terasima, T., Umezawa, H.: Lethal effect of bleomycin on cultured mammalian cells. J. Antibiot. A23, 300–304 (1970).
Tevethia, F., Rapp, F.: Effect of phleomycin on the replication of papova virus SV40 and other DNA viruses in simian cells. Cancer Res. 29, 912–917 (1969).
Tomizawa, H., Takahashi, H.: Stimulation of pectolytic enzyme formation of Erwinia aroides by nalidixic acid, mitomycin C and bleomycin. Agr. Biol. Chem. 35, 191–200 (1971).
Tsuboi, A., Terasima, T.: Rejoining of single breaks of DNA induced by x-rays in mammalian cells: effects of metabolic inhibitors. Molec. gen. Genetics 108, 117–128 (1970).
Ueno, M.: Clinical use of bleomycin in cases of cancer of the oral cavity. J. Jap. med. Assoc. 62, 117–126 (1969) (in Japanese).
Umezawa, H.: Bleomycin and other antitumor antibiotics of high molecular weight. Antimicrob. Ag. Chemother. 1965, 1079–1085 (1966).
Umezawa, H.: Index of antibiotics from actinomycetes. Tokyo: University Park Press and University of Tokyo Press 1967.
Umezawa, H., Hori, M., Ishizuka, M., Takeuchi, T.: Studies on antitumor effect of phleomycin. J. Antibiot. A15, 274–275 (1962).
Umezawa, H., Ishizuka, M., Hori, S., Chimura, H., Takeuchi, T., Komai, T.: The distribution of 3H-bleomycin in mouse tissue. J. Antibiot. A21, 638–642 (1968b).
Umezawa, H., Ishizuka, M., Kimura, K., Iwanaga, J., Takeuchi,T.: Biological studies on individual bleomycins. J. Antibiot. A21, 592–602 (1968a).
Umezawa, H., Ishizuka, M., Maeda, K., Takeuchi, T.: Studies on bleomycin. Cancer 20, 891–895 (1967).
Umezawa, H., Maeda, K.: Phleomycin, a new antibiotic substance. Japanese patent publication 2598/59, filed December 22, 1955 (translated by Kawase and Okada, Tokyo, 1959 ).
Umezawa, H., Maeda, K., Takeuchi, T., Okami, Y.: New antibiotics, bleomycin A and B. J. Antibiot. A19, 200–209 (1966a).
Umezawa, H., Suhara, Y., Ikekawa, T., Ishizuka, M., Hori, M., Maeda, K., Tanaka, N., Takeuchi, T.: Antitumor substances selected from streptomyces products. Int. Congr. Chemother. 1963, 974–978 (1964).
Umezawa, H., Suhara, Y., Takita, T., Maeda, K.: Purification of bleomycins. J. Antibiot. A19, 210–215 (1966b).
Watanabe, M., August, J. T.: Replication of RNA bacteriophage R23. II. Inhibition of phage specific UNA synthesis by phleomycin. J. molec. Biol. 33, 21–33 (1968).
Welsh, R., Vyska, K.: Properties of a new form of DNA from whole calf thymus nuclei: evidence for reactive special sites in DNA. Arch. Biochem. Biophys. 142, 132–143 (1971).
Werner, R.: Nature of DNA precursors. Nature New Biol. 233, 99–103 (1971).
Yamagata, S., Uzuka, Y., Kurokawa, Y., YoSahara, M.: Cancer chemotherapy. Current status and prospects. J. Jap. Soc. Cancer Ther. 3, 8–17 (1968) (in Japanese).
Yamaki, H., Tanaka, N., Umezawa, H.: Effects of several tumor-inhibitory antibiotics on immunological responses. J. Antibiot. A22, 315–321 (1969).
Zimmer, D. E.: Efficacy of some antifungal substances for scontrol of seedling safflower rust. Plant Dis. Rep. 49, 623–626 (1965).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 springer-Verlag Berlin-Heidelberg
About this chapter
Cite this chapter
Pietsch, P. (1975). Phleomycin and Bleomycin. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65806-8_49
Download citation
DOI: https://doi.org/10.1007/978-3-642-65806-8_49
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65808-2
Online ISBN: 978-3-642-65806-8
eBook Packages: Springer Book Archive